Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you live in Crowborough and you're weighing up Mounjaro as a weight-loss option, the most important thing to know first is this: tirzepatide is a prescription-only medicine in the UK, which means access depends on a clinical assessment, not a postcode. Your town doesn't determine eligibility — your health picture does. A GPhC-registered prescriber reviews every application individually, and that review can happen online the same day you apply, wherever you are in East Sussex. Mounjaro (tirzepatide) is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside a qualifying health condition such as high blood pressure or type 2 diabetes. Because it's a prescription-only medicine, a prescriber assesses your full clinical picture before any treatment is approved.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Not really, and that's the decision worth clarifying early. Mounjaro is dispensed by pharmacy, not by GP surgery geography, so living in Crowborough rather than a larger town puts you at no practical disadvantage. The question isn't whether a local clinic stocks it; it's whether you're clinically suitable and how you'd prefer to access it.
There are broadly two routes. The NHS route runs through a GP referral into a specialist weight-management service; NHS eligibility criteria for tirzepatide are strict and phased, currently requiring a BMI of 40 or above alongside multiple qualifying conditions. Waiting lists for those services vary significantly. The private route (through a regulated online pharmacy) removes the waiting-list problem but requires the same clinical rigour: a prescriber still assesses you, checks your medical history, and decides suitability before anything is dispensed.
If you're unsure which route suits your situation, our guide to getting Mounjaro through a GP explains the NHS pathway in plain terms, including how the referral process works and what the current NHS eligibility thresholds actually mean in practice.
The practical decision for most people in Crowborough comes down to three things: whether you meet NHS criteria now, how long you're willing to wait, and whether private prescription is affordable over the months treatment typically runs.
The licensed eligibility criteria for Mounjaro in the UK are set by the medicine's authorisation, not by local commissioning. Privately, that means adults with a BMI of 30 or above qualify for a clinical assessment, as do adults with a BMI between 27 and 29.9 who have at least one weight-related condition, prediabetes, diagnosed hypertension, high cholesterol, obstructive sleep apnoea and osteoarthritis are among the conditions that count. Lower BMI thresholds can apply for some ethnic backgrounds under UK guidance.
Eligibility isn't only about the number on the BMI calculator. A prescriber looks at your full health picture: current medications, any history of pancreatitis or thyroid conditions, whether you're pregnant or planning to become pregnant. These questions exist because Mounjaro isn't appropriate for everyone who meets the BMI threshold, and a careful consultation protects you as much as it screens you.
You can check your BMI in under a minute using the NHS BMI calculator before you fill in any consultation form, it's a useful first check, even if it's not the final word.
NICE's appraisal of tirzepatide (NICE TA1026) sets out the NHS-specific eligibility thresholds, which are stricter than the private licensed criteria. Understanding the difference between the two saves a lot of confusion when you start researching.
Most people starting Mounjaro notice gastrointestinal effects in the early weeks: nausea is the most commonly reported, sometimes accompanied by loose stools, constipation, or indigestion. These effects tend to be most noticeable after each dose increase and generally ease as your body settles at a given level. Starting at 2.5 mg, rather than jumping straight to a higher dose, is specifically designed to reduce this early-adjustment discomfort.
Serious side effects are less common but matter. The MHRA highlighted acute pancreatitis as an infrequent but known risk with GLP-1 class medicines in a January 2026 Drug Safety Update; the symptom to act on quickly is severe stomach pain that spreads to the back, especially if vomiting accompanies it. If that happens, seek urgent medical help rather than waiting for your next appointment.
Women taking the oral contraceptive pill should be aware that Mounjaro can affect its absorption during the first four weeks of treatment and for four weeks after each dose increase, adding a barrier method during those periods is the practical guidance. Our full Mounjaro overview covers interactions, storage and what to do if you miss a dose, in more detail than we'd sensibly fit here.
If you notice an unfamiliar symptom while on treatment, a persistent cough is one of the unexpected symptoms that people on Mounjaro ask about more than you might expect, and worth raising with your prescriber rather than dismissing.
Wherever you access Mounjaro privately, the cost picture in the UK shifted significantly from September 2025 when Eli Lilly raised its list price. Typical private prices since then have ranged roughly £149 to £375 per month depending on dose and provider, as widely reported at the time. If you're comparing providers, a UK price comparison for Mounjaro sets out what those figures typically include, and what some headline prices leave out.
One thing worth doing before you hand over any details to an online pharmacy: search the GPhC register at pharmacyregulation.org/registers and confirm the pharmacy appears on it. The MHRA has documented large seizures of counterfeit weight-loss pens sold through social media and unregistered sellers, including the first UK site found manufacturing fake tirzepatide pens, raided in 2025. A thirty-second check on the register is the simplest way to confirm a pharmacy is operating legally.
At nume, our pharmacy carries GPhC registration number 9012878, verifiable directly on that register. Medicines are sourced through the licensed UK supply chain, and every consultation is reviewed by a GPhC-registered Independent Prescriber, a real clinician, not automated triage. Orders placed before 12pm on weekdays are dispatched the same day once clinically approved and arrive the next working day via DPD, in plain packaging. One transparent price covers the consultation, prescription, and delivery; there are no subscriptions or hidden renewal charges.
If you're planning to travel while on treatment, our guide to taking Mounjaro through airport security is worth reading before you pack your medication. If you'd like to understand more about who reviews applications and what our clinical process involves, our clinical team page is worth a read before you decide. And if you have questions that don't fit neatly into a consultation form, our team is available seven days a week.
When you're ready, start your free consultation to have your clinical picture reviewed the same day by a prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.